Expression of V3 versican by rat arterial smooth muscle cells promotes differentiated and anti-inflammatory phenotypes

Journal of Biological Chemistry

Volumn 290, Issue 35, 2015, Pages 21629-21641

  Kang, Inkyung ^a   Barth, Jeremy L ^b   Sproul, Erin P ^b   Yoon, Dong Won ^a   Workman, Gail A ^a   Braun, Kathleen R ^a   Argraves, W Scott ^b   Wight, Thomas N ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CELLS; CYTOLOGY; GENES; MUSCLE; RATS; TRANSCRIPTION; TRANSCRIPTION FACTORS;

ANTI-INFLAMMATORIES; CCAAT/ENHANCER-BINDING PROTEINS; CHEMOKINE RECEPTORS; EXTRACELLULAR MATRICES; INFLAMMATORY PROCESS; LIPID ACCUMULATIONS; PATHOLOGICAL PROCESS; SMOOTH MUSCLE CELLS;

GENE EXPRESSION;

CCAAT ENHANCER BINDING PROTEIN BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOCARDIN; UNCLASSIFIED DRUG; V3 VERSICAN; VERSICAN; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; MICROARRAY ANALYSIS; MUSCLE FIBER CONTRACTION; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SMOOTH MUSCLE FIBER; ANIMAL; APOPTOSIS; ARTERY; CLUSTER ANALYSIS; COMPUTER PROGRAM; CYTOLOGY; DNA MICROARRAY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; FISCHER 344 RAT; GENE EXPRESSION PROFILING; GENETICS; INFLAMMATION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; TUMOR MICROENVIRONMENT; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ARTERIES; BIOMARKERS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR MICROENVIRONMENT; CLUSTER ANALYSIS; DOWN-REGULATION; GENE EXPRESSION PROFILING; INFLAMMATION; MOLECULAR SEQUENCE ANNOTATION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RATS, INBRED F344; RESPONSE ELEMENTS; SOFTWARE; UP-REGULATION; VERSICANS;

EID: 84940518400     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.657486     Document Type: Article

References (68)

1. Wight, T. N., Kang, I., and Merrilees, M. J. (2014) Versican and the control of inflammation. Matrix Biol. 35, 152-161
2. Chang, M. Y., Tanino, Y., Vidova, V., Kinsella, M. G., Chan, C. K., Johnson, P. Y., Wight, T. N., and Frevert, C. W. (2014) A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease. Matrix Biol. 34, 1-12
3. Henderson, D. J., and Copp, A. J. (1998) Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ. Res. 83, 523-532
4. Mjaatvedt, C. H., Yamamura, H., Capehart, A. A., Turner, D., and Markwald, R. R. (1998) The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 202, 56-66
5. Toeda, K., Nakamura, K., Hirohata, S., Hatipoglu, O. F., Demircan, K., Yamawaki, H., Ogawa, H., Kusachi, S., Shiratori, Y., and Ninomiya, Y. (2005) Versican is induced in infiltrating monocytes in myocardial infarction. Mol. Cell. Biochem. 280, 47-56
6. Wight, T. N., and Merrilees, M. J. (2004) Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 94, 1158-1167
7. Evanko, S. P., Johnson, P. Y., Braun, K. R., Underhill, C. B., Dudhia, J., and Wight, T. N. (2001) Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch. Biochem. Biophys. 394, 29-38
8. Shimizu-Hirota, R., Sasamura, H., Mifune, M., Nakaya, H., Kuroda, M., Hayashi, M., and Saruta, T. (2001) Regulation of vascular proteoglycan synthesis by angiotensin II type 1 and type 2 receptors. J. Am. Soc. Nephrol. 12, 2609-2615
9. Selbi, W., de la Motte, C. A., Hascall, V. C., Day, A. J., Bowen, T., and Phillips, A. O. (2006) Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int. 70, 1287-1295
10. Potter-Perigo, S., Johnson, P. Y., Evanko, S. P., Chan, C. K., Braun, K. R., Wilkinson, T. S., Altman, L. C., and Wight, T. N. (2010) Polyinosinepolycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am. J. Respir. Cell Mol. Biol. 43, 109-120
11. Hirose, J., Kawashima, H., Yoshie, O., Tashiro, K., and Miyasaka, M. (2001) Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 276, 5228-5234
12. Kim, S., Takahashi, H., Lin, W. W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J. L., and Karin, M. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106
13. Taylor, K. R., and Gallo, R. L. (2006) Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation. FASEB J. 20, 9-22
14. Wang, W., Xu, G. L., Jia, W. D., Ma, J. L., Li, J. S., Ge, Y. S., Ren, W. H., Yu, J. H., and Liu, W. B. (2009) Ligation of TLR2 by versican: a link between inflammation and metastasis. Arch. Med. Res. 40, 321-323
15. Wu, Y. J., La Pierre, D. P., Wu, J., Yee, A. J., and Yang, B. B. (2005) The interaction of versican with its binding partners. Cell Res. 15, 483-494
16. Hernández, D., Miquel-Serra, L., Docampo, M. J., Marco-Ramell, A., Cabrera, J., Fabra, A., and Bassols, A. (2011) V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling. J. Biol. Chem. 286, 1475-1485
17. Miquel-Serra, L., Serra, M., Hernández, D., Domenzain, C., Docampo, M. J., Rabanal, R. M., de Torres, I., Wight, T. N., Fabra, A., and Bassols, A. (2006) V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis. Lab. Invest. 86, 889-901
18. Serra, M., Miquel, L., Domenzain, C., Docampo, M. J., Fabra, A., Wight, T. N., and Bassols, A. (2005) V3 versican isoform expression alters the phenotype of melanoma cells and their tumorigenic potential. Int. J. Cancer 114, 879-886
19. Kern, C. B., Norris, R. A., Thompson, R. P., Argraves, W. S., Fairey, S. E., Reyes, L., Hoffman, S., Markwald, R. R., and Mjaatvedt, C. H. (2007) Versican proteolysis mediates myocardial regression during outflow tract development. Dev. Dyn. 236, 671-683
20. Henderson, D. J., Ybot-Gonzalez, P., and Copp, A. J. (1997) Over-expression of the chondroitin sulphate proteoglycan versican is associated with defective neural crest migration in the Pax3 mutant mouse (splotch). Mech. Dev. 69, 39-51
21. Mayanil, C. S., George, D., Freilich, L., Miljan, E. J., Mania-Farnell, B., McLone, D. G., and Bremer, E. G. (2001) Microarray analysis detects novel Pax3 downstream target genes. J. Biol. Chem. 276, 49299-49309
22. Kamiya, N., Watanabe, H., Habuchi, H., Takagi, H., Shinomura, T., Shimizu, K., and Kimata, K. (2006) Versican/PG-M regulates chondrogenesis as an extracellular matrix molecule crucial for mesenchymal condensation. J. Biol. Chem. 281, 2390-2400
23. Hinek, A., Braun, K. R., Liu, K., Wang, Y., and Wight, T. N. (2004) Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am. J. Pathol. 164, 119-131
24. Lemire, J. M., Merrilees, M. J., Braun, K. R., and Wight, T. N. (2002) Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J. Cell Physiol. 190, 38-45
25. Merrilees, M. J., Lemire, J. M., Fischer, J. W., Kinsella, M. G., Braun, K. R., Clowes, A. W., and Wight, T. N. (2002) Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ. Res. 90, 481-487
26. Merrilees, M. J., Beaumont, B. W., Braun, K. R., Thomas, A. C., Kang, I., Hinek, A., Passi, A., and Wight, T. N. (2011) Neointima formed by arterial smooth muscle cells expressing versican variant v3 is resistant to lipid and macrophage accumulation. Arterioscler. Thromb. Vasc. Biol. 31, 1309-1316
27. Kang, I., Yoon, D. W., Braun, K. R., and Wight, T. N. (2014) Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκ)- dependent signaling pathways, creating a microenvironment that resists monocyte adhesion. J. Biol. Chem. 289, 15393-15404
28. Clowes, M. M., Lynch, C. M., Miller, A. D., Miller, D. G., Osborne, W. R., and Clowes, A. W. (1994) Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J. Clin. Invest. 93, 644-651
29. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159
30. Allen, D. L., Bandstra, E. R., Harrison, B. C., Thorng, S., Stodieck, L. S., Kostenuik, P. J., Morony, S., Lacey, D. L., Hammond, T. G., Leinwand, L. L., Argraves, W. S., Bateman, T. A., and Barth, J. L. (2009) Effects of spaceflight on murine skeletal muscle gene expression. J. Appl. Physiol. 106, 582-595
31. Barth, J. L., Clark, C. D., Fresco, V. M., Knoll, E. P., Lee, B., Argraves, W. S., and Lee, K. H. (2010) Jarid2 is among a set of genes differentially regulated by Nkx2.5 during outflow tract morphogenesis. Dev. Dyn. 239, 2024-2033
32. Gacchina, C. E., Deb, P., Barth, J. L., and Ramamurthi, A. (2011) Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms. Tissue Eng. Part A 17, 1699-1711
33. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J., Scherf, U., and Speed, T. P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264
34. Edgar, R., and Barrett, T. (2006) NCBI GEO standards and services for microarray data. Nat. Biotechnol. 24, 1471-1472
35. Gonye, G. E., Chakravarthula, P., Schwaber, J. S., and Vadigepalli, R. (2007) From promoter analysis to transcriptional regulatory network prediction using PAINT. Methods Mol. Biol. 408, 49-68
36. Vadigepalli, R., Chakravarthula, P., Zak, D. E., Schwaber, J. S., and Gonye, G. E. (2003) PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 7, 235-252
37. Koshman, Y. E., Chu, M., Engman, S. J., Kim, T., Iyengar, R., Robia, S. L., and Samarel, A. M. (2011) Focal adhesion kinase-related nonkinase inhibits vascular smooth muscle cell invasion by focal adhesion targeting, tyrosine 168 phosphorylation, and competition for p130(Cas) binding. Arterioscler. Thromb. Vasc. Biol. 31, 2432-2440
38. Morla, A. O., and Mogford, J. E. (2000) Control of smooth muscle cell proliferation and phenotype by integrin signaling through focal adhesion kinase. Biochem. Biophys. Res. Commun. 272, 298-302
39. Huang, D., Khoe, M., Befekadu, M., Chung, S., Takata, Y., Ilic, D., and Bryer-Ash, M. (2007) Focal adhesion kinase mediates cell survival via NF-κB and ERK signaling pathways. Am. J. Physiol. Cell Physiol. 292, C1339-C1352
40. Urbinati, C., Bugatti, A., Giacca, M., Schlaepfer, D., Presta, M., and Rusnati, M. (2005) α(v)β3-integrin-dependent activation of focal adhesion kinase mediates NF-κB activation and motogenic activity by HIV-1 Tat in endothelial cells. J. Cell Sci. 118, 3949-3958
41. Petzold, T., Orr, A. W., Hahn, C., Jhaveri, K. A., Parsons, J. T., and Schwartz, M. A. (2009) Focal adhesion kinase modulates activation of NF-κB by flow in endothelial cells. Am. J. Physiol. Cell Physiol. 297, C814-C822
42. Mitra, S. K., Hanson, D. A., and Schlaepfer, D. D. (2005) Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6, 56-68
43. McGowan, S., Jackson, S. K., Jenkins-Moore, M., Dai, H. H., Chambon, P., and Snyder, J. M. (2000) Mice bearing deletions of retinoic acid receptors demonstrate reduced lung elastin and alveolar numbers. Am. J. Respir. Cell Mol. Biol. 23, 162-167
44. Liu, B., Harvey, C. S., and McGowan, S. E. (1993) Retinoic acid increases elastin in neonatal rat lung fibroblast cultures. Am. J. Physiol. 265, L430-L437
45. Owens, G. K., Kumar, M. S., and Wamhoff, B. R. (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767-801
46. Zako, M., Shinomura, T., Ujita, M., Ito, K., and Kimata, K. (1995) Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues. J. Biol. Chem. 270, 3914-3918
47. Paulus, W., Baur, I., Dours-Zimmermann, M. T., and Zimmermann, D. R. (1996) Differential expression of versican isoforms in brain tumors. J. Neuropathol. Exp. Neurol. 55, 528-533
48. Perissinotto, D., Iacopetti, P., Bellina, I., Doliana, R., Colombatti, A., Pettway, Z., Bronner-Fraser, M., Shinomura, T., Kimata, K., Mörgelin, M., Löfberg, J., and Perris, R. (2000) Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. Development 127, 2823-2842
49. Cattaruzza, S., Schiappacassi, M., Ljungberg-Rose, A., Spessotto, P., Perissinotto, D., Mörgelin, M., Mucignat, M. T., Colombatti, A., and Perris, R. (2002) Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro. J. Biol. Chem. 277, 47626-47635
50. Koga, T., Inatani, M., Hirata, A., Inomata, Y., Zako, M., Kimata, K., Oohira, A., Gotoh, T., Mori, M., and Tanihara, H. (2005) Expression of a chondroitin sulfate proteoglycan, versican (PG-M), during development of rat cornea. Curr. Eye Res. 30, 455-463
51. Hartwig, S., Raschke, S., Knebel, B., Scheler, M., Irmler, M., Passlack, W., Muller, S., Hanisch, F. G., Franz, T., Li, X., Dicken, H. D., Eckardt, K., Beckers, J., de Angelis, M. H., Weigert, C., et al. (2014) Secretome profiling of primary human skeletal muscle cells. Biochim. Biophys. Acta 1844, 1011-1017
52. Keire, P. A., L'Heureux, N., Vernon, R. B., Merrilees, M. J., Starcher, B., Okon, E., Dusserre, N., McAllister, T. N., and Wight, T. N. (2010) Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs. Tissue Eng. Part A 16, 501-512
53. Keire, P. A., Bressler, S. L., Lemire, J. M., Edris, B., Rubin, B. P., Rahmani, M., McManus, B. M., van de Rijn, M., and Wight, T. N. (2014) A role for versican in the development of leiomyosarcoma. J. Biol. Chem. 289, 34089-34103
54. Campbell, J. H., and Campbell, G. R. (1994) The role of smooth muscle cells in atherosclerosis. Curr. Opin. Lipidol. 5, 323-330
55. Worth, N. F., Rolfe, B. E., Song, J., and Campbell, G. R. (2001) Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil. Cytoskeleton 49, 130-145
56. Beamish, J. A., He, P., Kottke-Marchant, K., and Marchant, R. E. (2010) Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng. Part B Rev. 16, 467-491
57. Mack, C. P. (2011) Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler. Thromb. Vasc. Biol. 31, 1495-1505
58. Wang, X., Hu, G., and Zhou, J. (2010) Repression of versican expression by microRNA-143. J. Biol. Chem. 285, 23241-23250
59. Rangrez, A. Y., Massy, Z. A., Metzinger-Le Meuth, V., and Metzinger, L. (2011) miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells. Circ. Cardiovasc. Genet. 4, 197-205
60. Björkerud, S. (1991) Effects of transforming growth factor-β1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb. 11, 892-902
61. Hautmann, M. B., Madsen, C. S., and Owens, G. K. (1997) A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle ô-actin gene expression in concert with two CArG elements. J. Biol. Chem. 272, 10948-10956
62. Taylor, J. M., Mack, C. P., Nolan, K., Regan, C. P., Owens, G. K., and Parsons, J. T. (2001) Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells. Mol. Cell. Biol. 21, 1565-1572
63. Sayers, R. L., Sundberg-Smith, L. J., Rojas, M., Hayasaka, H., Parsons, J. T., Mack, C. P., and Taylor, J. M. (2008) FRNK expression promotes smooth muscle cell maturation during vascular development and after vascular injury. Arterioscler. Thromb. Vasc. Biol. 28, 2115-2122
64. Gupta, N., Khan, R., Kumar, R., Kumar, L., and Sharma, A. (2015) Versican and its associated molecules: Potential diagnostic markers for multiple myeloma. Clin. Chim. Acta 442, 119-124
65. Wipff, P. J., Rifkin, D. B., Meister, J. J., and Hinz, B. (2007) Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix. J. Cell Biol. 179, 1311-1323
66. DuFort, C. C., Paszek, M. J., and Weaver, V. M. (2011) Balancing forces: architectural control of mechanotransduction. Nat. Rev. Mol. Cell Biol. 12, 308-319
67. Iwasaki, H., Eguchi, S., Ueno, H., Marumo, F., and Hirata, Y. (2000) Mechanical stretch stimulates growth of vascular smooth muscle cells via epidermal growth factor receptor. Am. J. Physiol. Heart Circ. Physiol. 278, H521-H529
68. Paszek, M. J., DuFort, C. C., Rossier, O., Bainer, R., Mouw, J. K., Godula, K., Hudak, J. E., Lakins, J. N., Wijekoon, A. C., Cassereau, L., Rubashkin, M. G., Magbanua, M. J., Thorn, K. S., Davidson, M. W., Rugo, H. S., et al. (2014) The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature 511, 319-325